Improving Minority Health in Rheumatic Disease (IMHeaRD)
Improving Minority Health in Rheumatic Disease (IMHeaRD)
批准号:
10709544
负责人:
JAMES C OATES
金额:
$32.19万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-25 至 2027-08-31
关键词:
ARHGEF5 geneAccelerationAchievementAddressAreaAutoimmunityBiologicalBiological MarkersBiological Specimen BanksBiopsyBlack raceBudgetsClinicClinicalClinical ResearchCollaborationsCollectionCommunitiesConsultationsDataData AnalysesData MartElectronic Health RecordEnrollmentEpigenetic ProcessFacultyFamily memberFibrosisFoundationsFundingFutureGeneticGoalsHealthHealth PromotionHormonesHuman ResourcesImmunologyIndustry CollaborationInformaticsInfrastructureInternationalKnowledgeLaboratoriesLinkLongitudinal cohortLupusMethodologyMethodsPathway interactionsPatient RecruitmentsPatientsPeripheral Blood Mononuclear CellPhenotypePilot ProjectsPopulationProcessProductivityQuality ControlReportingResearchResearch DesignResearch PersonnelResearch Project GrantsResearch SupportResourcesRheumatismRheumatologySamplingSclerodermaServicesSiteSkinSolidSpecimenSurveysSystemic Lupus ErythematosusSystemic SclerodermaTargeted ResearchTextTimeTranslational ResearchTranslationsVisitWorkanticancer researchbasebiobankcancer immunotherapyclinical carecommunity engagementcommunity partnershipdemographicsexperienceflexibilityhealth disparityhealth recordimprove minority healthimprovedinformatics infrastructurelipidomicsmembermicrobiomenoveloutreach clinicspatient populationphenotypic datarecruitremote consentresponsesample collectionsocial determinantsvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary – Clinical and Community Resource Core
The Clinical and Community Resource Core will build on the strong foundation established by the P60-funded
MCRC Patient Resource Core and the subsequent P30-funded Clinical and Community Resource (CCR) Core.
Since 2012 these cores have served a local, national, international, and corporate base by providing a well
phenotyped longitudinal cohort of predominantly Black systemic lupus erythematosus (SLE) and systemic
sclerosis (SSc) patients and matched control and family member data and banked biological samples. The
improvements of the CCR Core have accelerated research among the expanding base by providing well
phenotyped specimens and data. A recent formal survey of the research base indicated a strong ongoing need
for existing services but expansion of services in critical areas. The proposed aims will continue the foundation
provided by the current CCCR infrastructure in a rigorous and transparent fashion. However, the renewed
Clinical and Community Resource Core (CCR Core) will flexibly expand services by 1) enhancing the informatics
infrastructure for remote consenting and survey completion, recruiting, health record data and text capture, and
reporting and 2) broadening sample collection to include a Living Biobank approach to just in time specimen
collection at any clinical laboratory encounter as well as MUSC Health sites across the state. Importantly, we
also have built strong relationships with the lay community. Because this community can inform research design,
improve enrollment and benefit from the knowledge of core personnel, the new CCR Core will continue
community engagement consultation services. The core’s specific aims are to: 1) Maintain and expand the CCR
Core with novel EHR, data mart, and reporting infrastructure to provide a well phenotyped, longitudinal cohort of
SLE and SSc subjects and matched control volunteers to support the current and future needs of the research
base. 2) Maintain and expand the CCR Core with novel EHR and Living BioBank infrastructure to efficiently
provide well phenotyped, banked and fresh biological specimens, both from within and beyond the longitudinal
cohort, based on the needs of the research base. 3) Provide resources to link communities impacted by SLE
and SSc and investigators. We will facilitate the engagement of community members and organizations into the
research process at every step, from project planning to dissemination and health promotion. 4) Provide
consultative & regulatory support to current and future projects of the research base. The overall goal of these
aims is to responsively expand the services of the Core to meet the needs of the research base. With an
expanding base, rigorous project management and quality control reporting and responses will be implemented
and maintained. No other resource can provide fine phenotype data and samples from this unique population of
patients. The community engagement facilitated by the core can increase the relevance of research performed
by the base as well as its translation to a community of SLE and SSc patients with known health disparities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predictive Biomarkers for disease activity and organ damage in patients with lupus
-
批准号:10152359
-
项目类别:
-
资助金额:$62.88万
-
财政年份:2018
-
负责人:JAMES C OATES
-
依托单位:
Predictive Biomarkers for disease activity and organ damage in patients with lupus
-
批准号:9925731
-
项目类别:
-
资助金额:$65.4万
-
财政年份:2018
-
负责人:JAMES C OATES
-
依托单位:
Predictive Biomarkers for disease activity and organ damage in patients with lupus
-
批准号:10400918
-
项目类别:
-
资助金额:$58.25万
-
财政年份:2018
-
负责人:JAMES C OATES
-
依托单位:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
-
批准号:10709535
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2017
-
负责人:JAMES C OATES
-
依托单位:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
-
批准号:10488451
-
项目类别:
-
资助金额:$75.09万
-
财政年份:2017
-
负责人:JAMES C OATES
-
依托单位:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
-
批准号:10488454
-
项目类别:
-
资助金额:$32.78万
-
财政年份:2017
-
负责人:JAMES C OATES
-
依托单位:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
-
批准号:10488452
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2017
-
负责人:JAMES C OATES
-
依托单位:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
-
批准号:10709534
-
项目类别:
-
资助金额:$74.5万
-
财政年份:2017
-
负责人:JAMES C OATES
-
依托单位:
Resource Core
-
批准号:10254242
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2017
-
负责人:JAMES C OATES
-
依托单位:
Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis
-
批准号:10487863
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:JAMES C OATES
-
依托单位:
Targeting Pathogenic Endothelial Dysfunction in Systemic Lupus Erythematosus
-
批准号:9137798
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:JAMES C OATES
-
依托单位:
Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis
-
批准号:10657579
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:JAMES C OATES
-
依托单位:
Urine biomarkers of lupus nephritis pathology and response to therapy
-
批准号:8259689
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:JAMES C OATES
-
依托单位:
Urine biomarkers of lupus nephritis pathology and response to therapy
-
批准号:7932421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:JAMES C OATES
-
依托单位:
Urine biomarkers of lupus nephritis pathology and response to therapy
-
批准号:8392947
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:JAMES C OATES
-
依托单位:
Urine biomarkers of lupus nephritis pathology and response to therapy
-
批准号:8195962
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:JAMES C OATES
-
依托单位:
THE ROLE OF NITRIC OXIDE AND EICOSANOIDS IN LUPUS NEPHRITIS
-
批准号:7719565
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:JAMES C OATES
-
依托单位:
PROTEOMIC APPROACH TO URINE BIOMARKERS OF DISEASE IN LUPUS NEPHRITIS
-
批准号:7719579
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2008
-
负责人:JAMES C OATES
-
依托单位:
BIOMARKERS OF ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
-
批准号:7719592
-
项目类别:
-
资助金额:$1.24万
-
财政年份:2008
-
负责人:JAMES C OATES
-
依托单位:
PROTEOMIC APPROACH TO URINE BIOMARKERS OF DISEASE IN LUPUS NEPHRITIS
-
批准号:7607159
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2007
-
负责人:JAMES C OATES
-
依托单位:
海外基金